Valhalla Flwr

Valhalla Flwr’s mix in August 2026 tilted toward Pre-Roll at 49.79% share, even as Pre-Roll declined month over month by 9.29% while growing 37.70% year over year; meanwhile, Flower held 43.55% share with a 19.44% month-over-month increase and a 78.62% year-over-year gain. Smaller but accelerating pockets emerged as Concentrates reached 5.05% share with 53.22% month-over-month growth and 370.92% year-over-year growth, contrasted by Vapor Pens at 1.62% share with a 38.36% month-over-month decline and a 22.09% year-over-year decline. With overall brand sales up 57.02% year over year and average price down 0.83%, the pattern implies a shift from a Pre-Roll-led profile toward a more balanced portfolio where Flower and Concentrates expand contribution even as the brand maintains category breadth.

Positioning-wise, anchoring in Pre-Roll remains relevant given a rank of 17 in Pre-Roll within British Columbia, but the 9.29% month-over-month contraction and 37.70% year-over-year lift suggest reliance on seasonal or promotional surges rather than steady base gains, while Flower’s 19.44% month-over-month and 78.62% year-over-year increases indicate capacity to capture trading-up behavior despite an $83.25 average price. The outsized 370.92% year-over-year expansion in Concentrates alongside a 53.22% month-over-month rise, versus Vapor Pens’ 22.09% year-over-year and 38.36% month-over-month declines, points to reallocating innovation and shelf focus toward inhalables with higher velocity outside the pen format; this positioning implies the brand can defend share by leaning into Flower and Concentrates as growth engines while using Pre-Roll to sustain traffic and de-emphasizing Vapor Pens where returns are contracting.